Blog

"MicroMir" Research and Production Center ("MicroMir" RPC)
and the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology (FRCC ICMR) outlined the principle of selecting bacteriophages not for individual patients, but for the entire spectrum of bacteria causing nosocomial pneumonia in the intensive care unit.

A study by “Micromir” Research and Production Center has been published in Scientific Reports journal, demonstrating that bacteriophages can be used to combat biofilms of Friedlander's bacillus.

The Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) has added a veterinary drug for the treatment and prevention of bacterial etiology infections in poultry to the register of medicinal products.

The patent was received jointly by the scientists of the RPC “Micromir” and the Federal State Budgetary Scientific Institution “Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology” (FRCC ICMR).

Scientists at RPC "MicroMir" were the first to use a 3D Cell Explorer microscope to visualize phage lysis of bacteria in real time.

The results of using two bacteriophage compositions in the rehabilitation of patients after COVID-19 have been published in Viruses.

Why is the complex phage preparation more effective than individual bacteriophages.

The Potential of Phage Therapy for Post-COVID-19 Rehabilitation.

In our new video we share details of the activities of RPC Micromir.

On the effectiveness and safety of adaptive phage therapy technology in neurological critical care.

Bacteria, fungi and other tiny organisms together form a human microbiome.

In this article, you will know the characteristics of antibiotics and bacteriophages.